Summary Gastric cancer-related long non-coding RNA1 (GClnc1) is an emerging oncogenic regulator in multiple malignancies, including gastric, colorectal, ovarian, and bladder cancers, as well as osteosarcoma. It promotes proliferation, inhibits apoptosis, and enhances drug resistance and metastasis. Mechanistically, GCl...
Patients with de novo metastatic nasopharyngeal carcinoma were historically deemed incurable and treated with palliative intent. Emergence of potent systemic therapy in combination with local treatment for both locoregional and metastatic diseases has enabled long-term survival in some patients. This international guid...
Qiao-Juan Guo, Qin Liu, P. Bossi et al.· The Lancet Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.